Traws Pharma, Inc.

Historical 13F Holders

Symbol
TRAW
CUSIP
68232V884
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 68232V884 since 12/18/2024, largest first.

Filer % of Class Filed
Orbimed Advisors LLC 13D/A
11.9% 5/5/2026
Event 4/16/2026
Sirenia Capital Management LP 13G
9.9% 8/14/2026
Event 6/30/2026
Alyeska Investment Group, L.P. 13G
9.9% 2/14/2025
Event 12/31/2024
Ikarian Capital, LLC 13G/A
9.5% 8/14/2026
Event 6/30/2026
Perceptive Advisors LLC 13G/A
6.1% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Adage Capital Management, L.P. 13G/A
4.8% 8/12/2026
Event 6/30/2026
Ayrton Capital LLC 13G/A
4.3% 2/11/2026
Event 12/31/2025
Chernett Jorey 13G/A 0% 11/16/2026
Event 9/30/2026
Squadron Capital Management LLC 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 33 5.90 M $3.50M
2026 Q2 33 6.16 M $5.19M
2026 Q1 28 3.62 M $6.62M
2025 Q4 22 3.42 M $3.86M
2025 Q3 18 1.30 M $2.41M
2025 Q2 20 1.26 M $1.87M
2025 Q1 19 1.73 M $3.98M
2024 Q4 19 1.17 M $10.2M
2024 Q3 12 646 k $3.80M